Biotech Leaders Gather in Boston for the China Focus@BWB 2019
MyBioGate and CUBIO Innovation Center's conference brought together 400+ attendees from around the world to learn about China's healthcare and pharmaceutical industry.
BOSTON, Sept. 23, 2019 /PRNewswire-PRWeb/ -- Hosted by MyBioGate and CUBIO Innovation Center, sponsored by Simcere innovation, Jiangsu industrial technology institute, Merits & Tree law offices, Gracell Biotechnologies and Cello Health Bioconsulting, China Focus@BWB 2019 has taken place on September 10 at the Boston Convention and Exhibition Center in Boston.
The conference brought together 400+ attendees from around the world to learn about China's healthcare and pharmaceutical industry, hear about the latest NMPA regulatory and reimbursement reforms and implications. It also provides a valuable networking opportunity for attendees to meet with the decision-makers in the industry through pre-conference partnering.
The forum kicked off in the opening remark of Ms. Xinxin Li, Vice President of Strategic Cooperation of MyBioGate. "With the rise of China healthcare market and industry, there could be more therapeutics brought to the market, patient community can access better healthcare with lower cost and entrepreneurs developing new drugs can be supported and rewarded financially," Xinxin addressed.
During the following keynotes and panels, the speakers shared their opinions on wide ranging topics including cross-border partnership in a new era of globalization and innovation, Chinese biopharma's diverse strategies to meet the domestic and global needs of innovation.
Keynote speech: Katherine Anderson – Head of U.S. Life Science & Healthcare Relationship Banking, Silicon Valley Bank
"China's investors have shown continued interest in supporting the global Life Science and Healthcare innovation ecosystem with a staggering $17B invested during a four-year period. When aggregated, European countries lead the way with $5.4B raised from Chinese investors." Ms. Katherine Andersen, Head of U.S. Life Science & Healthcare Relationship Banking at Silicon Valley Bank addressed in her keynote speech "China's Role in Global Life Science and Healthcare".
Panel 4 Winning recipes in a competitive landscape of licensing – What can we learn from the experiences of recent deal makers?
The organizers of China Focus@BWB also invited the innovative projects to participate at the event's featured session: Pitch & Match and MyBioGate Global Healthcare Innovation Competition, generated fruitful results, based on attendees. Enterprises from China and the United States also carried out comprehensive exhibitions of their enterprise from products, brand concept and core competitiveness.
This second annual China Focus@BWB conference was also held with an evening salon sponsored by Simcere innovation. Harvey Lodish, Ph.D., Founding Member and Professor, Whitehead Institute for Biomedical Research/MIT, Gordon J. Freeman, Ph.D., Professor of Medicine, Harvard Medical School, and Z. Alex Xu, M.D., Ph.D., Chief Scientist, CFDA/CDE brought remarkable speech on cutting-edge technological achievements in new therapies, new opportunities that China's recent drug regulatory reforms bring up.
Harvey Lodish – Founding Partner and Professor, Whitehead Institute of Biomedical Research/MIT
Last year, China Focus gathered 109 attendees in Boston for the very first meeting. "Over the past year, MyBioGate organized China Focus in Boston, San Francisco, Vienna and Philadelphia, gathered more than 1300 life science executives from all over the world," Ms. Xinxin Li addressed during the conference, "MyBioGate will continue to make China Focus a platform for all stakeholders to explore opportunities associated with the rising China healthcare market."
For more information, please visit: https://events.mybiogate.com/biotechweekboston/
Mybiogate's next event China Focus @Europe Hamburg is slated for November 10 at Grand Elysée Hamburg, Hamburg, Germany(https://events.mybiogate.com/europe/).
About China Focus
China Focus is bringing together investors, pharma leaders and innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations. The forum features premier 1-to-1 networking opportunities prior to and during the forum.
For questions and inquiries:
Feier Chen
Marketing Manager
7707 Fannin Street
Ste. 200
Houston, TX 77054
United States
Phone: (832) 497-2220
Email: [email protected]
Source: MyBioGate Inc.(https://events.mybiogate.com/)
###
SOURCE MyBioGate Inc.
Share this article